Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
Aneesha KohliLucie SauerheringSarah K FehlingKevin KlannHelmut GeigerStephan BeckerBenjamin KochPatrick C BaerThomas StreckerChristian MünchPublished in: Life science alliance (2022)
Acute kidney injury is associated with mortality in COVID-19 patients. However, host cell changes underlying infection of renal cells with SARS-CoV-2 remain unknown and prevent understanding of the molecular mechanisms that may contribute to renal pathology. Here, we carried out quantitative translatome and whole-cell proteomics analyses of primary renal proximal and distal tubular epithelial cells derived from human donors infected with SARS-CoV-2 or MERS-CoV to disseminate virus and cell type-specific changes over time. Our findings revealed shared pathways modified upon infection with both viruses, as well as SARS-CoV-2-specific host cell modulation driving key changes in innate immune activation and cellular protein quality control. Notably, MERS-CoV infection-induced specific changes in mitochondrial biology that were not observed in response to SARS-CoV-2 infection. Furthermore, we identified extensive modulation in pathways associated with kidney failure that changed in a virus- and cell type-specific manner. In summary, we provide an overview of the effects of SARS-CoV-2 or MERS-CoV infection on primary renal epithelial cells revealing key pathways that may be essential for viral replication.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- single cell
- endothelial cells
- acute kidney injury
- cell therapy
- quality control
- high glucose
- innate immune
- induced apoptosis
- type diabetes
- cell proliferation
- minimally invasive
- oxidative stress
- induced pluripotent stem cells
- cardiac surgery
- risk factors
- cardiovascular disease
- mesenchymal stem cells
- signaling pathway
- kidney transplantation